{"entity":{"type":"insider","cik":"0001256153","url":"/insider/0001256153","json_url":"/insider/0001256153.json","name":"LEVIN JEREMY M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2017-08-28","last":"2024-03-20","span_basis":"filed_date"},"name_variants":[{"name":"LEVIN JEREMY M","source":"filing","n_filings":5,"first_seen":"2017-08-28","last_seen":"2024-03-20"}],"transactions":[{"id":2151567,"accession":"0001209191-24-005001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-005001","line_url":"/filing/0001209191-24-005001#line-1","is_derivative":false,"issuer_cik":"0001256153","issuer_name":"Ovid Therapeutics Inc.","issuer_ticker":"OVID","issuer_name_source":null,"issuer_url":"/issuer/0001256153","owner_cik":"0001256153","owner_name":"LEVIN JEREMY M","owner_display_name":"LEVIN JEREMY M","owner_url":"/insider/0001256153","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18248.0,"shares_display":"18,248","price_per_share":2.76,"price_display":"2.76","price_state":"stated","total_value":50364.48,"total_display":"50,364.48","total_whole":"50,364","shares_owned_after":3616715.0,"shares_owned_after_display":"3,616,715","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-18","filed_date":"2024-03-20","scope":"insider"},{"id":2042151,"accession":"0001209191-20-049011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-049011","line_url":"/filing/0001209191-20-049011#line-1","is_derivative":false,"issuer_cik":"0001256153","issuer_name":"Ovid Therapeutics Inc.","issuer_ticker":"OVID","issuer_name_source":null,"issuer_url":"/issuer/0001256153","owner_cik":"0001256153","owner_name":"LEVIN JEREMY M","owner_display_name":"LEVIN JEREMY M","owner_url":"/insider/0001256153","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8488.0,"shares_display":"8,488","price_per_share":5.84,"price_display":"5.84","price_state":"stated","total_value":49569.92,"total_display":"49,569.92","total_whole":"49,570","shares_owned_after":5792530.0,"shares_owned_after_display":"5,792,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-28","filed_date":"2020-09-01","scope":"insider"},{"id":7928463,"accession":"0001209191-19-052988","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-052988","line_url":"/filing/0001209191-19-052988#line-1","is_derivative":false,"issuer_cik":"0001256153","issuer_name":"Ovid Therapeutics Inc.","issuer_ticker":"OVID","issuer_name_source":null,"issuer_url":"/issuer/0001256153","owner_cik":"0001256153","owner_name":"LEVIN JEREMY M","owner_display_name":"LEVIN JEREMY M","owner_url":"/insider/0001256153","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":4736529.0,"shares_owned_after_display":"4,736,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-08","filed_date":"2019-10-10","scope":"insider"},{"id":8232491,"accession":"0001209191-19-013905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-013905","line_url":"/filing/0001209191-19-013905#line-1","is_derivative":false,"issuer_cik":"0001256153","issuer_name":"Ovid Therapeutics Inc.","issuer_ticker":"OVID","issuer_name_source":null,"issuer_url":"/issuer/0001256153","owner_cik":"0001256153","owner_name":"LEVIN JEREMY M","owner_display_name":"LEVIN JEREMY M","owner_url":"/insider/0001256153","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":4676529.0,"shares_owned_after_display":"4,676,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-22","filed_date":"2019-02-26","scope":"insider"},{"id":4163432,"accession":"0001209191-17-050467","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-050467","line_url":"/filing/0001209191-17-050467#line-1","is_derivative":false,"issuer_cik":"0001256153","issuer_name":"Ovid Therapeutics Inc.","issuer_ticker":"OVID","issuer_name_source":null,"issuer_url":"/issuer/0001256153","owner_cik":"0001256153","owner_name":"LEVIN JEREMY M","owner_display_name":"LEVIN JEREMY M","owner_url":"/insider/0001256153","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15334.0,"shares_display":"15,334","price_per_share":7.15,"price_display":"7.15","price_state":"stated","total_value":109638.1,"total_display":"109,638.10","total_whole":"109,638","shares_owned_after":4601529.0,"shares_owned_after_display":"4,601,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-25","filed_date":"2017-08-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001636651","name":"Ovid Therapeutics Inc.","url":"/issuer/0001636651","role":"Director, Officer (CEO), Ten percent owner","n_filings":5,"first_seen":"2017-08-28","last_seen":"2024-03-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001256153","retrieved_at":"2026-08-25T12:15:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}